Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevonescein for Intra-Operative Visualization of Nerves in Head and Neck Surgery
NCT05377554Phase 3Completed
- Sponsor
- Alume Biosciences
- Start
- Apr 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 3 trial of bevonescein, sponsored by Alume Biosciences. Started Apr 2022; status: completed.
02
Drugs
bevonescein
Beyond the preview
Go deeper on NCT05377554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05377554.